{
  "abstract": "We would like to thank Dr Ichimasa and colleagues for their comments on our recent publication reporting the 3-year oncological outcomes of endoscopic intermuscular dissection (EID) for deep submucosal invasive rectal cancer.1 2 We appreciate their engagement with our work and welcome the opportunity to address the points they raised.",
  "authors": [
    {
      "affiliations": [
        "Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, Netherlands",
        "Cancer Center Amsterdam, Amsterdam, Netherlands"
      ],
      "name": "Sander C Albers"
    },
    {
      "affiliations": [
        "Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands"
      ],
      "name": "Lisa van der Schee"
    },
    {
      "affiliations": [
        "Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, Netherlands",
        "Cancer Center Amsterdam, Amsterdam, Netherlands"
      ],
      "name": "Barbara A J Bastiaansen"
    },
    {
      "affiliations": [
        "Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands"
      ],
      "name": "Leon M G Moons"
    }
  ],
  "title": "Response to: ‘Endoscopic intermuscular dissection for rectal cancer: are we ready to skip surgery?’ by Ichimasa et al",
  "uid": "58aee91d-0fe2-58bd-9d50-2db5f3d18168"
}
